UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US

PloS one, 2018-03, Vol.13 (3), p.e0194799

2018

Volltextzugriff (PDF)

The late‐presenting HIV‐infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis

HIV medicine, 2017-02, Vol.18 (2), p.125-132

2017

Volltextzugriff (PDF)

Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000–2017: Protective effects of non-injecting drug use

Drug and alcohol dependence, 2018-11, Vol.192, p.74-79

2018

Volltextzugriff (PDF)

Geographic distribution of risk ("Hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history

Harm reduction journal, 2019-09, Vol.16 (1), p.53-12, Article 53

2019

Volltextzugriff (PDF)

Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

HIV medicine, 2015-04, Vol.16 (S1), p.46-54

2015

Volltextzugriff (PDF)

HIV‐positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C

Journal of viral hepatitis, 2017-10, Vol.24 (10), p.832-839

2017

Volltextzugriff (PDF)

Effect of gender and race on the week 48 findings in treatment‐naïve, HIV‐1‐infected patients enrolled in the randomized, phase III trials ECHO and THRIVE

HIV medicine, 2012-08, Vol.13 (7), p.406-415

2012

Volltextzugriff (PDF)

Retention of participants in opiate substitution programs in low and middle-income countries: An international systematic review

Drug and alcohol dependence, 2014-07, Vol.140, p.e49-e50

2014

Volltextzugriff (PDF)

Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City

AIDS and behavior, 2014-03, Vol.18 (3), p.443-451

2014

Volltextzugriff (PDF)

The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy

HIV medicine, 2011-01, Vol.12 (1), p.31-39

2011

Volltextzugriff (PDF)

Hepatitis C virus-specific immune responses in noninjecting drug users

Journal of viral hepatitis, 2012-08, Vol.19 (8), p.554-559

2012

Volltextzugriff (PDF)

Treatment of spondylodiscitis in human immunodeficiency virus-infected patients: a comparison of conservative and operative therapy

Spine (Philadelphia, Pa. 1976), 2009-06, Vol.34 (13), p.E452-E458

2009

Volltextzugriff (PDF)

Twenty‐four‐week efficacy and safety of switching virologically suppressed HIV‐1‐infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION)

HIV medicine, 2012-04, Vol.13 (4), p.236-244

2012

Volltextzugriff (PDF)

Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study

Annals of oncology, 2006-06, Vol.17 (6), p.914-919

2006

Volltextzugriff (PDF)

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

The New England journal of medicine, 2013-11, Vol.369 (19), p.1807-1818

2013

Volltextzugriff (PDF)

'Time-to-amphotericin B' in cryptococcal meningitis in a European low-prevalence setting: analysis of diagnostic delays

QJM : An International Journal of Medicine, 2014-10, Vol.107 (10), p.799-803

2014

Volltextzugriff (PDF)

Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT)

European journal of medical research, 2009-05, Vol.14 (5), p.195-195

2009

Volltextzugriff (PDF)

Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis

Journal of Clinical Microbiology, 1994-11, Vol.32 (11), p.2813-2819

1994

Volltextzugriff (PDF)

Imported leishmaniasis in Germany 2001-2004 : data of the SIMPID surveillance network

European journal of clinical microbiology & infectious diseases, 2005-07, Vol.24 (7), p.471-476

2005

Volltextzugriff (PDF)

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

The New England journal of medicine, 2008-07, Vol.359 (4), p.339-354

2008

Volltextzugriff (PDF)

Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery

Infection, 2005-06, Vol.33 (3), p.140-147

2005

Volltextzugriff (PDF)

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

The New England journal of medicine, 2008-07, Vol.359 (4), p.355-365

2008

Volltextzugriff (PDF)

Efavirenz-induced osteomalacia

AIDS (London), 2009-01, Vol.23 (2), p.274-275

2009

Volltextzugriff (PDF)

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.587-596

2013

Volltextzugriff (PDF)

1 – 25 von 220

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(189)
Mit Volltextzugriff
(164)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(184)
Deutsch
(36)

Erscheinungsjahr

n.n

Thema

Humans
(135)
Science & Technology
(129)
Life Sciences & Biomedicine
(117)
Male
(106)
Adult
(96)
Female
(87)
Middle Aged
(70)
Biological And Medical Sciences
(68)
Medical Sciences
(67)
Infectious Diseases
(64)
Human Immunodeficiency Virus
(58)
Hiv
(55)
Hiv Infections - Drug Therapy
(54)
Aids/hiv
(51)
Human Viral Diseases
(33)
Viral Diseases
(33)
Cd4 Lymphocyte Count
(31)
Pharmacology. Drug Treatments
(31)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(31)
Aged
(29)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US

The late‐presenting HIV‐infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis

Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000–2017: Protective effects of non-injecting drug use

Geographic distribution of risk ("Hotspots") for HIV, HCV, and drug overdose among persons who use drugs in New York City: the importance of local history

Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

HIV‐positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C

Effect of gender and race on the week 48 findings in treatment‐naïve, HIV‐1‐infected patients enrolled in the randomized, phase III trials ECHO and THRIVE

Retention of participants in opiate substitution programs in low and middle-income countries: An international systematic review

Combined HIV Prevention, the New York City Condom Distribution Program, and the Evolution of Safer Sex Behavior Among Persons Who Inject Drugs in New York City

The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy

Hepatitis C virus-specific immune responses in noninjecting drug users

Treatment of spondylodiscitis in human immunodeficiency virus-infected patients: a comparison of conservative and operative therapy

Twenty‐four‐week efficacy and safety of switching virologically suppressed HIV‐1‐infected patients from nevirapine immediate release 200 mg twice daily to nevirapine extended release 400 mg once daily (TRANxITION)

Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

'Time-to-amphotericin B' in cryptococcal meningitis in a European low-prevalence setting: analysis of diagnostic delays

Switch from a ZDV/3TC-based regimen to a completely once daily (QD) regimen of emtricitabine/tenofovir DF fixed dose combination plus a third QD agent (SONETT)

Value of PCR for evaluating occurrence of parasitemia in immunocompromised patients with cerebral and extracerebral toxoplasmosis

Imported leishmaniasis in Germany 2001-2004 : data of the SIMPID surveillance network

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4+ T cell recovery

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

Efavirenz-induced osteomalacia

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

Suchergebnisse filtern